Show simple item record

dc.contributor.authorChan, Keith
dc.contributor.authorTu, D
dc.contributor.authorKlarkowski, D
dc.contributor.authorO'Brien, Daniel P
dc.contributor.authorMills, C
dc.contributor.authorElema, R
dc.contributor.authorVerputten, M
dc.contributor.authorBedell, R
dc.contributor.authorOlaiya, M
dc.contributor.authorBraker, K
dc.contributor.authorShanks, L
dc.contributor.authorHogg, R
dc.date.accessioned2008-06-04T12:30:06Z
dc.date.available2008-06-04T12:30:06Z
dc.date.issued2006
dc.identifier.urihttp://hdl.handle.net/10144/29481
dc.description2006 AIDS Conference, Torontoen
dc.language.isoenen
dc.titleField testing of World Health Organization (WHO) 2003 recommendations for initiating anti-retroviral therapy (ART) where CD4 is not available revealed low sensitivity among stage I and II patients; a combination of Automated Total Lymphocyte Count (TLC) and Haemoglobin (Hgb) can ration the referral for CD4 testing.en
refterms.dateFOA2019-03-04T10:34:14Z


Files in this item

Thumbnail
Name:
A_THPE0169.pdf
Size:
50.99Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record